HLB Life Science Co., Ltd. (067630.KQ)
KRW 9780.0
(-1.81%)
KRW 9780.0
(-1.81%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -54.79 KRW | 89.06% |
| 2022 | -537.56 KRW | -8.65% |
| 2021 | -494.76 KRW | 12.21% |
| 2020 | -563.59 KRW | -838.26% |
| 2019 | 76.34 KRW | 126.76% |
| 2018 | -285.30 KRW | -309.3% |
| 2017 | 136.31 KRW | 712.9% |
| 2016 | -22.24 KRW | 95.34% |
| 2015 | -477.00 KRW | -1106.97% |
| 2014 | 47.37 KRW | 117.8% |
| 2013 | -266.14 KRW | 64.92% |
| 2012 | -758.56 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -1333.00 KRW | -198.15% |
| 2024 Q1 | 1358.14 KRW | 2042.51% |
| 2023 Q2 | -96.10 KRW | -171.58% |
| 2023 Q4 | 63.39 KRW | 139.55% |
| 2023 Q3 | -160.29 KRW | -66.8% |
| 2023 FY | - KRW | 89.06% |
| 2023 Q1 | 134.26 KRW | 122.04% |
| 2022 Q2 | 62.03 KRW | 163.61% |
| 2022 Q4 | -609.29 KRW | -652.69% |
| 2022 Q3 | 110.24 KRW | 77.72% |
| 2022 FY | - KRW | -8.65% |
| 2022 Q1 | -97.52 KRW | 84.09% |
| 2021 Q2 | -163.44 KRW | -4.62% |
| 2021 Q4 | -612.93 KRW | -235.76% |
| 2021 Q1 | -156.22 KRW | 64.68% |
| 2021 Q3 | 451.47 KRW | 376.23% |
| 2021 FY | - KRW | 12.21% |
| 2020 Q2 | 15.10 KRW | 105.93% |
| 2020 FY | - KRW | -838.26% |
| 2020 Q4 | -442.31 KRW | -472.13% |
| 2020 Q3 | 118.86 KRW | 687.15% |
| 2020 Q1 | -254.65 KRW | -257.74% |
| 2019 Q3 | -123.13 KRW | -149.55% |
| 2019 Q2 | -49.34 KRW | 41.74% |
| 2019 Q1 | -84.69 KRW | 69.89% |
| 2019 FY | - KRW | 126.76% |
| 2019 Q4 | 161.44 KRW | 231.11% |
| 2018 Q4 | -281.28 KRW | -668.93% |
| 2018 Q3 | 49.44 KRW | 100.32% |
| 2018 Q2 | 24.68 KRW | 217.13% |
| 2018 Q1 | -21.07 KRW | -112.68% |
| 2018 FY | - KRW | -309.3% |
| 2017 Q1 | -3.05 KRW | -112.75% |
| 2017 Q3 | -5.78 KRW | -78.95% |
| 2017 Q4 | 166.21 KRW | 2975.61% |
| 2017 Q2 | -3.23 KRW | -5.9% |
| 2017 FY | - KRW | 712.9% |
| 2016 Q3 | -35.55 KRW | -306.75% |
| 2016 Q4 | 23.93 KRW | 167.31% |
| 2016 FY | - KRW | 95.34% |
| 2016 Q2 | -8.74 KRW | -99.09% |
| 2016 Q1 | -4.39 KRW | 96.52% |
| 2015 Q1 | -45.21 KRW | -235.93% |
| 2015 Q2 | -259.99 KRW | -475.07% |
| 2015 Q4 | -126.09 KRW | -47.34% |
| 2015 Q3 | -85.58 KRW | 67.08% |
| 2015 FY | - KRW | -1106.97% |
| 2014 Q1 | -2.47 KRW | 97.1% |
| 2014 Q2 | 9.54 KRW | 486.23% |
| 2014 FY | - KRW | 117.8% |
| 2014 Q3 | 6.18 KRW | -35.22% |
| 2014 Q4 | 33.26 KRW | 438.19% |
| 2013 Q2 | -108.53 KRW | -125.68% |
| 2013 Q3 | -36.58 KRW | 66.3% |
| 2013 Q4 | -85.30 KRW | -133.19% |
| 2013 FY | - KRW | 64.92% |
| 2013 Q1 | -48.09 KRW | 91.04% |
| 2012 Q3 | -58.95 KRW | 0.0% |
| 2012 FY | - KRW | 0.0% |
| 2012 Q4 | -536.54 KRW | -810.16% |
| Name | Eps | Eps Difference |
|---|